Today is proving to be a stellar day for several biotech stocks. However, there are a few that are surely outperforming the market overall today. In a quick search, I was able to find 4 biotech stocks with double digit gains…
Aoxing Pharmaceutical Company Is Today’s Biggest Gainer In Biotech
Aoxing Pharmaceutical Company Inc (NYSEMKT: AXN)
AXN is having an incredible day in the market today; earning it’s way to the position, Biggest Gainer in Biotech. Currently (1:45) Aoxing Pharmaceutical Company shares are trading at $2.75 each after a massive gain of 58.96% so far today. Following investor sentiment in market social media like Stock Twits, it seems as though the climb is likely to continue; at least for a short while. From a technical standpoint, now may be the time to start looking for pullbacks for great entrance opportunities. It’s definitely one to keep an eye on.
Oculus Innovative Sciences Stock Gains On High Volume
Oculus Innovative Sciences, Inc. (NASDAQ: OCLS)
OCLS shares are trading hands on high volume today. As I mentioned in a post earlier today, the volume we saw in the morning more than 30 times normal volume; leading the stock into highs. Since morning trading, we’ve seen relatively flat movement as the stock takes a rest; however, it’s likely to continue its climb tomorrow as a clear flag with growing support is starting to emerge in the chart. Currently (1:52), OCLS is trading at $1.65 per share after a gain of 22.22% so far today.
POZEN Stock Gains on Acquisition
POZEN Inc. (NASDAQ: POZN)
POZN is another big gainer today following news of an acquisition. POZEN will acquire Tribute Pharmaceuticals Canada Inc., a company that focuses on specialty pharmaceuticals. The acquisition is valued at about $146 million and will be completed in the fourt quarter of 2015. As a result, the stock is currently trading at $9.10 per share after a gain of 20.21% so far today. This one has already started to pull back; it may be a great opportunity for making an entrance.
MannKind Corporation Continues Its Bullish Trend
MannKind Corporation (NASDAQ: MNKD)
MannKind has had an incredible time in the market recently; breaking it’s long term downtrend after a survey from Jefferies showed that endocrinologists not only know about Afrezza, but plan to use it more often in the future. Currently (1:57), MNKD is trading at $7.23 per share after a gain of 18.14% so far today. Moving forward, I’m not expecting an end to these gains anytime soon. So, as with the other stocks mentioned in this post, keep an eye out for pull backs leading to buying opportunities.
Do You Know Of Any Other Great Opportunities?
Let us know in the comments below!